1177:HKG
Sino Biopharmaceutical Ltd
HK$5.25
arrow_downward
-0.38%(-0.020) 1H
16 Okt, 4:08:14 PTG GMT+8 · HKD
search
Semua simbol
| Simbol | Harga | Perubahan | % Perubahan |
|---|
insights_autoMenjana cerapan popular untuk 1177...
Buka
HK$5.40
Tinggi
HK$5.50
Rendah
HK$5.14
Permodalan Pasaran
98.09B
Purata volum
69.33J
Volum
83.88J
Dividen
2.29%
Dividen suku tahunan
HK$0.03
Tarikh tanpa dividen
29 Ogo 2025
Nisbah H/P
33.86
tgi 52 mgu
HK$7.79
rdh 52 mgu
HK$4.19
EPS
HK$0.16
Syer tertunggak
12.64B
Bilangan pekerja
23K
Buka
HK$5.40
Tinggi
HK$5.50
Rendah
HK$5.14
Permodalan Pasaran
98.09B
Purata volum
69.33J
Volum
83.88J
Dividen
2.29%
Dividen suku tahunan
HK$0.03
Tarikh tanpa dividen
29 Ogo 2025
Nisbah H/P
33.86
tgi 52 mgu
HK$7.79
rdh 52 mgu
HK$4.19
EPS
HK$0.16
Syer tertunggak
12.64B
Bilangan pekerja
23K
Cerita berita
Daripada sumber web dan rakan kongsi berita
ad-hoc-news.de
·
1 hari lalu
Sino Biopharm reports 10.60 percent growth for Sino Biopharm stock
Profil
Sino Biopharmaceutical Limited, shortly SBP Group, is a pharmaceutical conglomerate in China. The Company was listed on the Hong Kong Stock Exchange in 2000 and included in 2013 as a constituent stock of MSCI Global Standard Indices – MSCI China Index, Hang Seng Index in 2018, Hang Seng China Enterprises Index in 2019, and Hang Seng Connect Biotech 50 Index and Hang Seng China 25 Index in 2020.
The Group’s principal subsidiaries include: Chia Tai Tianqing Pharmaceutical Group Co. Ltd., Beijing Tide Pharmaceutical Co. Ltd., Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd., Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd., Jiangsu Chia Tai Qingjiang Pharmaceutical Co., Ltd. and invoX Pharma Limited. Its products including biopharmaceutical and chemical medicines are used in a host of therapeutic areas, such as tumors, liver diseases, respiratory system diseases and surgery/analgesia. Wikipedia
Perihal Sino Biopharmaceutical Ltd